These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 3388293)

  • 1. Clinical experience with a pasteurised human plasma concentrate in factor XIII deficiency.
    Daly HM; Haddon ME
    Thromb Haemost; 1988 Apr; 59(2):171-4. PubMed ID: 3388293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pasteurised concentrate of human plasma factor XIII for therapeutic use.
    Winkelman L; Sims GE; Haddon ME; Evans DR; Smith JK
    Thromb Haemost; 1986 Jun; 55(3):402-5. PubMed ID: 3750269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of congenital insufficiency in fibrin stabilising factor (FSF or factor XIII) by purified factor XIII of placental origin. Report of two cases with a four year follow up].
    Caille B; Vergoz D; Vie JC; Braive JP; Capron F; Duriez S; Sarrade-Loucheur C; Ferrer F
    Ann Pediatr (Paris); 1977 Dec; 24(12):837-42. PubMed ID: 16218265
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and safety of prophylactic treatment with plasma-derived factor XIII concentrate (human) in patients with congenital factor XIII deficiency.
    Ashley C; Chang E; Davis J; Mangione A; Frame V; Nugent DJ
    Haemophilia; 2015 Jan; 21(1):102-8. PubMed ID: 25377187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital deficiency of factor XIII caused by two missense mutations in a Dutch family.
    Onland W; Böing AN; Meijer AB; Schaap MC; Nieuwland R; Haasnoot K; Sturk A; Peters M
    Haemophilia; 2005 Sep; 11(5):539-47. PubMed ID: 16128900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of a novel mutation in the factor XIII a subunit gene associated with a severe defect: importance of prophylactic substitution.
    Morange P; Trigui N; Frère C; Chambost H; Pouymayou C; Uters M; Boucly C; Juhan-Vague I; de Mazancourt P
    Blood Coagul Fibrinolysis; 2009 Oct; 20(7):605-6. PubMed ID: 19713833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A patient whose factor XIII level was decreased by double filtrate plasmapheresis and successfully recovered by infusion of factor XIII concentrate.
    Hanafusa N; Aozasa N; Fujita T
    Ther Apher Dial; 2010 Aug; 14(4):432-3. PubMed ID: 20649765
    [No Abstract]   [Full Text] [Related]  

  • 8. Prophylaxis in rare coagulation disorders -- factor XIII deficiency.
    Nugent DJ
    Thromb Res; 2006; 118 Suppl 1():S23-8. PubMed ID: 16616323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and safety of plasma-derived factor XIII concentrate (human) in patients with congenital factor XIII deficiency.
    Nugent DJ; Ashley C; García-Talavera J; Lo LC; Mehdi AS; Mangione A
    Haemophilia; 2015 Jan; 21(1):95-101. PubMed ID: 25458735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor XIII deficiency.
    Hsieh L; Nugent D
    Haemophilia; 2008 Nov; 14(6):1190-200. PubMed ID: 19141159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proceedings: Factor XIII concentrate in the long term management of congenital factor XIII deficiency.
    Miloszewski K; Losowsky MS
    Thromb Diath Haemorrh; 1975 Sep; 34(1):323-4. PubMed ID: 810913
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic factor XIII preparations and perspectives for recombinant factor XIII.
    Karges HE; Metzner HJ
    Semin Thromb Hemost; 1996; 22(5):427-36. PubMed ID: 8989827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital factor XIII deficiency with treatment of factor XIII concentrate and normal vaginal delivery.
    Kobayashi T; Terao T; Kojima T; Takamatsu J; Kamiya T; Saito H
    Gynecol Obstet Invest; 1990; 29(3):235-8. PubMed ID: 2358199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The half life of factor XIII in the management of inherited deficiency.
    Fear JD; Miloszewski KJ; Losowsky MS
    Thromb Haemost; 1983 Apr; 49(2):102-5. PubMed ID: 6868004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Congenital factor XIII deficiency required high-dose factor XIII concentrate in late pregnancy].
    Takahashi T; Hatao K; Suzukawa M; Oji T
    Rinsho Ketsueki; 2007 May; 48(5):418-20. PubMed ID: 17571589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A short half-life of the administered factor XIII (FXIII) concentrates after the first replacement therapy in a newborn with severe congenital FXIII deficiency.
    Fujii N; Souri M; Ichinose A
    Thromb Haemost; 2012 Mar; 107(3):592-4. PubMed ID: 22234520
    [No Abstract]   [Full Text] [Related]  

  • 17. An unusual clinical presentation of factor XIII deficiency and issues relating to the monitoring of factor XIII replacement therapy.
    Dargaud Y; de Mazancourt P; Rugeri L; Hanss M; Borg JY; Gaucherand P; Negrier C; Trzeciak C
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):447-52. PubMed ID: 18600098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor concentrates for the treatment of factor XIII deficiency.
    Gootenberg JE
    Curr Opin Hematol; 1998 Nov; 5(6):372-5. PubMed ID: 9814641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inherited factor XIII deficiency.
    Waks D; Arnout J; Demulder A; Ferster A; Fondu P
    Acta Clin Belg; 1989; 44(1):52-7. PubMed ID: 2763783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Factor XIII deficiency due to lack of both the S and A subunits. (Classification of factor XIII deficiency in 2 groups)].
    Girolami A; Burul A; Cappellato MG; Betterle C; Casonato A; Dal Bo Zanon R
    Ric Clin Lab; 1979; 9(2 Suppl):35-49. PubMed ID: 395620
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.